Takeda Pharmaceutical (4502.T) PEG Ratio
Market Cap: $7.16T
Avg Volume: 4.12M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
PEG Ratio Summary
- Takeda Pharmaceutical's trailing twelve month (TTM) PEG ratio is -1.21.
- Takeda Pharmaceutical's annual PEG ratio as of today is -0.82.
- Takeda Pharmaceutical's quarterly PEG ratio is -0.94.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Takeda Pharmaceutical's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: 45.16
- Quarterly: 69.56
- TTM: 34.38
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 1.53
- Quarterly: 5.79
- TTM: 1.56
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 0.89
- Quarterly: 0.89
- TTM: 0.96
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: 9.08
- Quarterly: 17.25
- TTM: 6.66
These metrics provide insights into Takeda Pharmaceutical's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-1.21
Annual PEG Ratio
-0.82
Quarterly PEG Ratio
-0.94
Takeda Pharmaceutical Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Takeda Pharmaceutical Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | -0.82 | 45.16 | 1.53 | 0.89 | 9.08 |
| 2023 | 0.55 | 21.29 | 1.68 | 1.06 | 6.91 |
| 2022 | -0.61 | 23.77 | 1.53 | 0.96 | 4.87 |
| 2021 | 0.02 | 16.55 | 1.95 | 1.20 | 6.16 |
| 2020 | -1.97 | 116.44 | 1.57 | 1.09 | 7.69 |
| 2019 | -0.93 | 65.76 | 3.42 | 1.39 | 21.85 |
| 2018 | 0.69 | 43.50 | 4.59 | 4.07 | 21.52 |
| 2017 | 1.63 | 71.36 | 4.74 | 4.33 | 31.38 |
| 2016 | -0.48 | 100.49 | 4.46 | 4.13 | 316.03 |
| 2015 | 0.38 | -64.55 | 5.29 | 4.40 | 51.55 |
| 2014 | -2.55 | 71.94 | 4.54 | 3.11 | 51.73 |
| 2013 | 2.91 | 57.13 | 4.81 | 3.47 | 24.37 |
| 2012 | -0.92 | 46.05 | 3.79 | 2.84 | 16.99 |
| 2011 | -1.47 | 24.55 | 4.29 | 2.91 | 18.61 |
| 2010 | 0.72 | 21.68 | 4.40 | 3.04 | 16.93 |
Related Metrics
Explore detailed financial metrics and analysis for 4502.T.